Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia

BACKGROUND: An individualised risk-stratified screening for prostate cancer (PCa) would select the patients who will benefit from further investigations as well as therapy. Current detection methods suffer from low sensitivity and specificity, especially for separating PCa from benign prostatic cond...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Br J Cancer
Main Authors: Giskeødegård, Guro F, Hansen, Ailin Falkmo, Bertilsson, Helena, Gonzalez, Susana Villa, Kristiansen, Kåre Andre, Bruheim, Per, Mjøs, Svein A, Angelsen, Anders, Bathen, Tone Frost, Tessem, May-Britt
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2015
Fag:
Molecular Diagnostics
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4702000/
https://ncbi.nlm.nih.gov/pubmed/26633561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.411
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker